Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rovazolac (ALX-101) is a liver x receptor (LXR) modulator used in the study of immune system disorders and atopic dermatitis.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 17,000 | |||
5 mg | 在庫あり | ¥ 41,000 | |||
10 mg | 在庫あり | ¥ 66,500 | |||
25 mg | 在庫あり | ¥ 133,000 | |||
50 mg | 在庫あり | ¥ 205,000 | |||
100 mg | 在庫あり | ¥ 312,500 | |||
500 mg | 在庫あり | ¥ 626,500 |
説明 | Rovazolac (ALX-101) is a liver x receptor (LXR) modulator used in the study of immune system disorders and atopic dermatitis. |
In vitro | Rovazolac is often used as a liver X receptor (LXR) agonist in vitro[1]. |
別名 | ALX-101 |
分子量 | 452.45 |
分子式 | C21H19F3N2O4S |
CAS No. | 1454288-88-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 8 mg/mL (17.68 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rovazolac 1454288-88-0 Metabolism Liver X Receptor ALX-101 Inhibitor inhibitor inhibit